|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's range||10.00 - 10.37|
|52-week range||8.79 - 41.48|
|Beta (5Y monthly)||1.39|
|PE ratio (TTM)||5.19|
|Earnings date||08 Aug 2022 - 12 Aug 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||14.17|
The two 3D printing companies recently released their first-quarter results. Here's how they stacked up in a metric-by-metric comparison.
Dr. Stephen K. Klasko Dr. Stephen K. Klasko ROCK HILL, S.C., May 16, 2022 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE:DDD) announced the formation of the company’s first Medical Advisory Board (MAB) and the appointment of Stephen K. Klasko, MD, MBA as Chair. The primary mission of the MAB will be to provide strategic input, guidance, and recommendations for the company’s emerging regenerative medicine efforts as they begin moving from research into advanced development and, ultimately, into huma
DDD, AMRN, and BDX have been added to the Zacks Rank #5 (Strong Sell) List on May 13, 2022.